Atropine sulfate ophthalmic solution is an anticholinergic (parasympatholytic) drug used topically in the eye to produce mydriasis (pupil dilation) and cycloplegia (paralysis of the ciliary muscle). It is a critical medication in veterinary ophthalmology, used across species for the management of uveitis (intraocular inflammation), to prevent posterior synechiae (adhesions between the iris and lens), and as a diagnostic mydriatic. In equine ophthalmology, atropine is a cornerstone of uveitis treatment but requires careful monitoring due to the risk of systemic anticholinergic effects in horses.
Overview
Atropine blocks muscarinic acetylcholine receptors in the iris sphincter muscle and ciliary body, causing the pupil to dilate (mydriasis) and the ciliary muscle to relax (cycloplegia). In uveitis, this dilation helps prevent the inflamed iris from adhering to the lens capsule (posterior synechiae), which can cause permanent pupil distortion and secondary glaucoma. Cycloplegia also reduces ciliary body spasm, which contributes to the pain of uveitis.
Atropine is available as a 1% ophthalmic solution and, less commonly, as a 1% ophthalmic ointment. In horses, the 1% solution is standard.
Uses
Horses:
- Equine recurrent uveitis (ERU / moon blindness) — primary indication; prevents synechiae and relieves ciliary spasm
- Traumatic anterior uveitis — following blunt or penetrating ocular trauma
- Uveitis secondary to corneal ulceration — reflex uveitis from corneal pain
- Diagnostic mydriasis — to allow thorough funduscopic examination
Dogs and Cats:
- Anterior uveitis — from infectious, immune-mediated, or traumatic causes
- Lens luxation-associated uveitis
- Pre-operative mydriasis — before intraocular surgery
- Diagnostic pupil dilation
Dosage
Use only as directed by your veterinarian.
| Species | Concentration | Dose | Frequency | Notes |
|---|---|---|---|---|
| Horses | 1% solution | 1-2 drops in affected eye | Every 6-12 hours initially; taper to 1-2 times daily as response permits | Monitor GI motility closely |
| Dogs | 1% solution | 1 drop in affected eye | Every 8-12 hours | Mydriasis lasts 72-96 hours in dogs |
| Cats | 1% solution | 1 drop in affected eye | Every 12-24 hours | Mydriasis lasts up to 72 hours in cats |
In horses: Start with more frequent dosing (every 4-6 hours) during acute severe uveitis to break or prevent synechiae, then taper to the minimum frequency needed to maintain mydriasis. Because of the risk of systemic effects in horses, the goal is to use the lowest effective frequency.
Duration of mydriasis varies by species. Horses: atropine-induced mydriasis may last 2-7 days or longer. Dogs and cats: 72-96 hours or longer. This long duration means that once adequate mydriasis is achieved, the dosing frequency can often be reduced.
Side Effects
Horses (systemic effects are a significant concern):
| Common | Serious (Contact Your Vet Immediately) |
|---|---|
| Mydriasis (intended effect) | Decreased GI motility / ileus |
| Photosensitivity (dilated pupil) | Colic (from reduced gut motility) |
| Impaction colic | |
| Tachycardia |
Important equine consideration: Horses absorb ophthalmic atropine systemically via the nasolacrimal duct and conjunctival vessels. This systemic absorption can cause clinically significant anticholinergic effects, most importantly decreased gastrointestinal motility. Reduced gut motility can lead to gas accumulation, impaction, and colic. Monitor your horse’s manure production, appetite, and gut sounds during atropine therapy. Report any decrease in manure output or signs of colic to your veterinarian immediately.
Dogs and Cats:
- Prolonged mydriasis and photosensitivity
- Decreased tear production (transient)
- Mild local irritation upon application
- Systemic effects are uncommon at ophthalmic doses
Drug Interactions
- Other anticholinergic drugs: Additive systemic effects (dry mouth, decreased GI motility, tachycardia).
- Pilocarpine and other miotics: Direct pharmacologic antagonism. Avoid concurrent use in the same eye unless specifically directed.
- In horses: concurrent use with drugs that decrease GI motility (alpha-2 agonists such as xylazine or detomidine) may compound the risk of ileus and colic.
- Topical ophthalmic NSAIDs (flurbiprofen, diclofenac): Often used concurrently for uveitis; no adverse interaction.
- Topical ophthalmic antibiotics: Commonly used concurrently when corneal ulceration is present; no adverse interaction.
Contraindications
- Glaucoma — atropine increases intraocular pressure by blocking aqueous humor outflow. It is contraindicated in primary glaucoma and in uveitis patients with secondary glaucoma (your veterinarian will assess intraocular pressure).
- Lens luxation with secondary glaucoma
- Known hypersensitivity to atropine
- Horses with active GI problems — use with extreme caution in horses with current or recent colic, ileus, or impaction
Storage
- Store at controlled room temperature, 59-77 degrees F (15-25 degrees C).
- Protect from light.
- Keep bottle tightly closed when not in use.
- Do not touch the dropper tip to the eye or any surface to prevent contamination.
- Discard after the expiration date or if the solution appears cloudy or discolored.
Frequently Asked Questions
Why does my horse’s gut slow down when I put drops in his eye? Atropine is absorbed through the eye’s blood vessels and the nasolacrimal duct into the systemic circulation. In horses, this systemic absorption can be enough to cause anticholinergic effects on the GI tract, reducing motility. This is why monitoring manure output during atropine therapy is important.
How can I minimize the GI side effects in my horse? Use the minimum effective dosing frequency. Once the pupil is dilated, you may be able to reduce to once daily or less. Your veterinarian will guide tapering. Pressing gently on the medial canthus (inner corner of the eye) for 30 seconds after applying drops can reduce systemic absorption through the nasolacrimal duct.
My horse’s pupil is still dilated days after stopping atropine. Is this normal? Yes. Atropine-induced mydriasis can persist for several days to a week after the last dose in horses. This is expected and will resolve on its own.
Can atropine cure equine recurrent uveitis? Atropine manages the symptoms and prevents complications (synechiae) of uveitis but does not cure the underlying disease. ERU is a chronic, recurrent condition that may require long-term management strategies including cyclosporine implants, systemic anti-inflammatory therapy, and regular ophthalmic monitoring.
This information is for educational purposes only and does not replace professional veterinary advice. Always consult your veterinarian before administering any medication to your animal.